tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide

C144H146Cl6F2N32O24 — CID 157194134

IUPACtert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
SMILESCCNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)OC(C)(C)C.CCNc1c([N+](=O)[O-])cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)OC(C)(C)C.CCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1CC.CCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2n1CC.CCn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.CCn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c21
InChIInChI=1S/C27H28ClFN6O3.C25H24ClFN6O3.C24H26ClN5O6.C24H28ClN5O4.C23H22ClN5O4.C21H18ClN5O4/c1-4-21-32-20-12-30-24-18(23(20)34(21)5-2)10-19(25(37)31-11-16-6-8-17(28)9-7-16)26(38)35(24)13-22(36)33-14-27(3,29)15-33;1-3-31-14-30-19-10-28-22-17(21(19)31)8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22)11-20(34)32-12-25(2,27)13-32;1-5-26-20-16-10-17(22(32)28-11-14-6-8-15(25)9-7-14)23(33)29(13-19(31)36-24(2,3)4)21(16)27-12-18(20)30(34)35;1-5-27-20-16-10-17(22(32)29-11-14-6-8-15(25)9-7-14)23(33)30(21(16)28-12-18(20)26)13-19(31)34-24(2,3)4;1-3-18-27-17-11-25-21-15(20(17)28(18)4-2)9-16(23(33)29(21)12-19(30)31)22(32)26-10-13-5-7-14(24)8-6-13;1-2-26-11-25-16-9-23-19-14(18(16)26)7-15(21(31)27(19)10-17(28)29)20(30)24-8-12-3-5-13(22)6-4-12/h6-10,12H,4-5,11,13-15H2,1-3H3,(H,31,37);4-8,10,14H,3,9,11-13H2,1-2H3,(H,29,35);6-10,12H,5,11,13H2,1-4H3,(H,26,27)(H,28,32);6-10,12H,5,11,13,26H2,1-4H3,(H,27,28)(H,29,32);5-9,11H,3-4,10,12H2,1-2H3,(H,26,32)(H,30,31);3-7,9,11H,2,8,10H2,1H3,(H,24,30)(H,28,29)
InChIKeyAQATTWPSZIVIEJ-UHFFFAOYSA-N
MW2959.67 g/mol
LogP18.83
Rot. Bonds41

About tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide

tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide (PubChem CID 157194134) has the molecular formula C144H146Cl6F2N32O24 and a molecular weight of 2959.67 g/mol. Its IUPAC name is tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide.

Molecular Properties

Compound Nametert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
PubChem CID157194134
Molecular FormulaC144H146Cl6F2N32O24
Molecular Weight2959.67 g/mol
Exact Mass2954.93
IUPAC Nametert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
SMILESCCNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)OC(C)(C)C.CCNc1c([N+](=O)[O-])cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)OC(C)(C)C.CCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1CC.CCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2n1CC.CCn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.CCn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c21
InChIInChI=1S/C27H28ClFN6O3.C25H24ClFN6O3.C24H26ClN5O6.C24H28ClN5O4.C23H22ClN5O4.C21H18ClN5O4/c1-4-21-32-20-12-30-24-18(23(20)34(21)5-2)10-19(25(37)31-11-16-6-8-17(28)9-7-16)26(38)35(24)13-22(36)33-14-27(3,29)15-33;1-3-31-14-30-19-10-28-22-17(21(19)31)8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22)11-20(34)32-12-25(2,27)13-32;1-5-26-20-16-10-17(22(32)28-11-14-6-8-15(25)9-7-14)23(33)29(13-19(31)36-24(2,3)4)21(16)27-12-18(20)30(34)35;1-5-27-20-16-10-17(22(32)29-11-14-6-8-15(25)9-7-14)23(33)30(21(16)28-12-18(20)26)13-19(31)34-24(2,3)4;1-3-18-27-17-11-25-21-15(20(17)28(18)4-2)9-16(23(33)29(21)12-19(30)31)22(32)26-10-13-5-7-14(24)8-6-13;1-2-26-11-25-16-9-23-19-14(18(16)26)7-15(21(31)27(19)10-17(28)29)20(30)24-8-12-3-5-13(22)6-4-12/h6-10,12H,4-5,11,13-15H2,1-3H3,(H,31,37);4-8,10,14H,3,9,11-13H2,1-2H3,(H,29,35);6-10,12H,5,11,13H2,1-4H3,(H,26,27)(H,28,32);6-10,12H,5,11,13,26H2,1-4H3,(H,27,28)(H,29,32);5-9,11H,3-4,10,12H2,1-2H3,(H,26,32)(H,30,31);3-7,9,11H,2,8,10H2,1H3,(H,24,30)(H,28,29)
InChIKeyAQATTWPSZIVIEJ-UHFFFAOYSA-N
XLogP18.83
TPSA716.26 Ų
H-Bond Donors11
H-Bond Acceptors45
Rotatable Bonds41
Heavy Atoms208
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002959.67
LogP ≤ 518.83
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1045

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The IUPAC name of tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide (CID 157194134) is tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide.
What is the SMILES notation for tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The canonical SMILES for tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide is CCNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)OC(C)(C)C.CCNc1c([N+](=O)[O-])cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)OC(C)(C)C.CCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1CC.CCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2n1CC.CCn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.CCn1cnc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c21.
What is the InChIKey of tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The InChIKey is AQATTWPSZIVIEJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H28ClFN6O3.C25H24ClFN6O3.C24H26ClN5O6.C24H28ClN5O4.C23H22ClN5O4.C21H18ClN5O4/c1-4-21-32-20-12-30-24-18(23(20)34(21)5-2)10-19(25(37)31-11-16-6-8-17(28)9-7-16)26(38)35(24)13-22(36)33-14-27(3,29)15-33;1-3-31-14-30-19-10-28-22-17(21(19)31)8-18(23(35)29-9-15-4-6-16(26)7-5-15)24(36)33(22)11-20(34)32-12-25(2,27)13-32;1-5-26-20-16-10-17(22(32)28-11-14-6-8-15(25)9-7-14)23(33)29(13-19(31)36-24(2,3)4)21(16)27-12-18(20)30(34)35;1-5-27-20-16-10-17(22(32)29-11-14-6-8-15(25)9-7-14)23(33)30(21(16)28-12-18(20)26)13-19(31)34-24(2,3)4;1-3-18-27-17-11-25-21-15(20(17)28(18)4-2)9-16(23(33)29(21)12-19(30)31)22(32)26-10-13-5-7-14(24)8-6-13;1-2-26-11-25-16-9-23-19-14(18(16)26)7-15(21(31)27(19)10-17(28)29)20(30)24-8-12-3-5-13(22)6-4-12/h6-10,12H,4-5,11,13-15H2,1-3H3,(H,31,37);4-8,10,14H,3,9,11-13H2,1-2H3,(H,29,35);6-10,12H,5,11,13H2,1-4H3,(H,26,27)(H,28,32);6-10,12H,5,11,13,26H2,1-4H3,(H,27,28)(H,29,32);5-9,11H,3-4,10,12H2,1-2H3,(H,26,32)(H,30,31);3-7,9,11H,2,8,10H2,1H3,(H,24,30)(H,28,29).
What are the key properties of tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide has a molecular weight of 2959.67 g/mol, XLogP of 18.83, 41 rotatable bonds, 11 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 2-[6-amino-3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-5-(ethylamino)-6-nitro-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1,2-diethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;2-[8-[(4-chlorophenyl)methylcarbamoyl]-1-ethyl-7-oxoimidazo[4,5-f][1,8]naphthyridin-6-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1,2-diethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide is sourced from PubChem (CID 157194134), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).